CONTENTS:
- Digital interventions for problematic cannabis users in non-clinical settings: Findings from a systematic review and meta-analysis. Hoch E., Preuss U.W., Ferri M., Simon R., p. 233-242.
- Urine ethyl glucuronide unraveling the reality of abstinence monitoring in a routine outpatient setting: A cross-sectional comparison with ethanol, self report and clinical judgment. Barrio P., Teixidor L., Rico N., Bruguera P., Ortega L., Bedini J.L., et al., p. 243-248.
- Methadone-related overdose deaths in a liberal opioid maintenance treatment programme. Tjagvad C., Skurtveit S., Linnet K., Andersen L.V., Christoffersen D.J., Clausen T., p. 249-258.
- Intravenous use of prescription psychostimulants; A comparison of the pattern and subjective experience between different methylphenidate preparations, amphetamine and cocaine. Bjarnadottir G.D., Magnusson A., Rafnar B.O., Sigurdsson E., Steingrimsson S., Johannsson M., et al., p. 259-267.
- Smoking cessation program for inpatients with substance use disorder: A quasi-randomized controlled trial of feasibility and efficacy. Ruther T., Ruderer A., Wirth C., Schuler V., Lang V., Linhardt A., et al., p. 268-276.
- Treatment seeking for alcohol use disorders: Treatment gap or adequate self-selection? Tuithof M., Ten Have M., van den Brink W., Vollebergh W., de Graaf R., p. 277-285.